GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » EV-to-EBITDA

Bavarian Nordic A/S (Bavarian Nordic A/S) EV-to-EBITDA : 3.72 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bavarian Nordic A/S's enterprise value is $1,402 Mil. Bavarian Nordic A/S's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $377 Mil. Therefore, Bavarian Nordic A/S's EV-to-EBITDA for today is 3.72.

The historical rank and industry rank for Bavarian Nordic A/S's EV-to-EBITDA or its related term are showing as below:

BVNRY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1450.96   Med: 10.53   Max: 1278.67
Current: 3.72

During the past 13 years, the highest EV-to-EBITDA of Bavarian Nordic A/S was 1278.67. The lowest was -1450.96. And the median was 10.53.

BVNRY's EV-to-EBITDA is ranked better than
59.11% of 472 companies
in the Biotechnology industry
Industry Median: 9.1 vs BVNRY: 3.72

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), Bavarian Nordic A/S's stock price is $7.046. Bavarian Nordic A/S's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.950. Therefore, Bavarian Nordic A/S's PE Ratio for today is 7.42.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bavarian Nordic A/S EV-to-EBITDA Historical Data

The historical data trend for Bavarian Nordic A/S's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S EV-to-EBITDA Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.63 11.85 189.99 74.62 5.65

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.62 14.70 8.55 5.56 5.65

Competitive Comparison of Bavarian Nordic A/S's EV-to-EBITDA

For the Biotechnology subindustry, Bavarian Nordic A/S's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's EV-to-EBITDA falls into.



Bavarian Nordic A/S EV-to-EBITDA Calculation

Bavarian Nordic A/S's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1401.606/376.691
=3.72

Bavarian Nordic A/S's current Enterprise Value is $1,402 Mil.
Bavarian Nordic A/S's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $377 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic A/S  (OTCPK:BVNRY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bavarian Nordic A/S's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.046/0.950
=7.42

Bavarian Nordic A/S's share price for today is $7.046.
Bavarian Nordic A/S's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.950.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bavarian Nordic A/S EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Q4 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2019 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S Conference Call Transcript

By GuruFocus Research 02-13-2024

Q3 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024